LOXO 305 and a Series of Videos from CURE Magazine

[bkoffman]

Hi,

CLL Society worked with CURE magazine to provide panel members to discuss their CLL journey and the changing way CLL should be treated in this nice series of 5 short videos: cllsociety.org/2020/02/cure....

At ASH 2019, Dr. Brown shared the exciting first in human trial data for LOXO 305 that has a new way to block BTK that is different than ibrutinib or acalabrutinib. See: cllsociety.org/2020/02/ash-...

Stay strong.

We are all in this together.

Brian

Brian Koffman MDCM (retired) MS Ed

Co-Founder, Executive VP and Chief Medical Officer

CLL Society, Inc

cllsociety.org

[Sushibruno]

I hope it turns out to be very successful. Cll needs to be gone for good "CURED"

[Justasheet1]

Doc,

Do you know how durable the response is? I understand that it was a small cohort but there seems to be a buzz about these non-covalent BTK’s.

Jeff

[bkoffman CLL CURE Hero in reply to Justasheet1]

No durability data yet.